Hedgehog Acyltransferase Promotes Uptake of Palmitoyl-CoA across the Endoplasmic Reticulum Membrane.

Cell Rep

Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Biochemistry, Cell Biology and Molecular Biology Graduate Program, Weill-Cornell Graduate School of Medical Sciences, New York, NY, USA. Electronic address:

Published: December 2019

Attachment of palmitate to the N terminus of Sonic hedgehog (Shh) is essential for Shh signaling. Shh palmitoylation is catalyzed on the luminal side of the endoplasmic reticulum (ER) by Hedgehog acyltransferase (Hhat), an ER-resident enzyme. Palmitoyl-coenzyme A (CoA), the palmitate donor, is produced in the cytosol and is not permeable across membrane bilayers. It is not known how palmitoyl-CoA crosses the ER membrane to access the active site of Hhat. Here, we use fluorescent and radiolabeled palmitoyl-CoA probes to demonstrate that Hhat promotes the uptake of palmitoyl-CoA across the ER membrane in microsomes and semi-intact cells. Reconstitution of purified Hhat into liposomes provided further evidence that palmitoyl-CoA uptake activity is an intrinsic property of Hhat. Palmitoyl-CoA uptake was regulated by and could be uncoupled from Hhat enzymatic activity, implying that Hhat serves a dual function as a palmitoyl acyltransferase and a conduit to supply palmitoyl-CoA to the luminal side of the ER.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948154PMC
http://dx.doi.org/10.1016/j.celrep.2019.11.110DOI Listing

Publication Analysis

Top Keywords

hedgehog acyltransferase
8
promotes uptake
8
uptake palmitoyl-coa
8
endoplasmic reticulum
8
luminal side
8
palmitoyl-coa uptake
8
palmitoyl-coa
7
hhat
7
acyltransferase promotes
4
uptake
4

Similar Publications

Background/aim: Glioblastoma is the most frequent type of adult-onset malignant brain tumor and has a very poor prognosis. Glioblastoma stem cells have been shown to be one of the mechanisms by which glioblastoma acquires therapy resistance. Therefore, there is a need to establish novel therapeutic strategies useful for inhibiting this cell population.

View Article and Find Full Text PDF
Article Synopsis
  • Phenotypic assays are valuable for detecting small molecules that influence cellular functions and can reveal new target interactions and biological insights.
  • An osteoblast differentiation assay using a Hedgehog signaling agonist identified a class of osteogenesis inhibitors known as pyrrolo[3,4-g]quinoline (PQ) compounds.
  • The most effective compound, Tafbromin, disrupts Hedgehog signaling by binding to TAF1's bromodomain 2, making it a promising resource for exploring biological processes related to TAF1(bromodomain 2).
View Article and Find Full Text PDF
Article Synopsis
  • - The genetic variant rs641738 C>T is linked to metabolic dysfunction-associated steatotic liver disease (MASH) and is associated with reduced levels of the enzyme MBOAT7, which is important for phospholipid remodeling, impacting liver health and fibrosis levels.
  • - Research on mice showed that restoring MBOAT7 expression helps slow liver fibrosis progression, while silencing it worsens fibrosis despite not affecting fat accumulation in the liver; this is connected to TAZ, a protein that promotes fibrosis.
  • - The study concluded that loss of MBOAT7 leads to changes in liver phospholipids that activate TAZ and increase a profibrotic factor, suggesting a potential for personalized medicine targeting TAZ to
View Article and Find Full Text PDF

Hedgehog signaling is involved in embryonic development and cancer growth. Functional activity of secreted Hedgehog signaling proteins is dependent on -terminal palmitoylation, making the palmitoyl transferase Hedgehog acyltransferase (HHAT), a potential drug target and a series of 4,5,6,7-tetrahydrothieno[3,2-]pyridines have been identified as HHAT inhibitors. Based on structural data, we designed and synthesized 37 new analogues which we profiled alongside 13 previously reported analogues in enzymatic and cellular assays.

View Article and Find Full Text PDF

NAA10 is a novel biomarker of cancer progression. The oncogenic and biological mechanisms of NAA10 in human malignancies are controversial and remain to be elucidated. Herein, we investigated the biological and clinicopathological implications of NAA10 gene expression in adult gliomas.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!